Evidence map›Paper›PMID 39384781›Full record

ArticleNature communications2024

NanoPlex: a universal strategy for fluorescence microscopy multiplexing using nanobodies with erasable signals.

Nikolaos Mougios, Elena R Cotroneo, Nils Imse, Jonas Setzke, Silvio O Rizzoli, Nadja A Simeth, Roman Tsukanov, Felipe Opazo

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Simulating Multicolor Super-Resolution Imaging Using an RGB Camera.Computational and structural biotechnology journal · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. A Rapid and Modular Nanobody Assay for Plug-and-Play Antigen Detection.bioRxiv : the preprint server for biology · 2025
    Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nikolaos MougiosInstitute of Neuro- and Sensory Physiology, University Medical Center Göttingen, Göttingen, Germany.
Elena R CotroneoInstitute for Organic and Biomolecular Chemistry, University of Göttingen, Göttingen, Germany.
Nils ImseInstitute for Organic and Biomolecular Chemistry, University of Göttingen, Göttingen, Germany.
Jonas SetzkeCenter for Biostructural Imaging of Neurodegeneration (BIN), University of Göttingen Medical Center, Göttingen, Germany.ORCID 0009-0000-5614-4378
Silvio O RizzoliInstitute of Neuro- and Sensory Physiology, University Medical Center Göttingen, Göttingen, Germany.ORCID 0000-0002-1667-7839
Nadja A SimethInstitute for Organic and Biomolecular Chemistry, University of Göttingen, Göttingen, Germany.ORCID 0000-0001-8130-883X
Roman TsukanovIII. Institute of Physics - Biophysics, Georg August University, Göttingen, Germany.ORCID 0000-0002-3967-1755
Felipe OpazoInstitute of Neuro- and Sensory Physiology, University Medical Center Göttingen, Göttingen, Germany. fopazo@gwdg.de.ORCID 0000-0002-4968-9713

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) SFB1286
6 · The paper itself

Abstract

Fluorescence microscopy has long been a transformative technique in biological sciences. Nevertheless, most implementations are limited to a few targets, which have been revealed using primary antibodies and fluorescently conjugated secondary antibodies. Super-resolution techniques such as Exchange-PAINT and, more recently, SUM-PAINT have increased multiplexing capabilities, but they require specialized equipment, software, and knowledge. To enable multiplexing for any imaging technique in any laboratory, we developed NanoPlex, a streamlined method based on conventional antibodies revealed by engineered secondary nanobodies that allow the selective removal of fluorescence signals. We develop three complementary signal removal strategies: OptoPlex (light-induced), EnzyPlex (enzymatic), and ChemiPlex (chemical). We showcase NanoPlex reaching 21 targets for 3D confocal analyses and 5-8 targets for dSTORM and STED super-resolution imaging. NanoPlex has the potential to revolutionize multi-target fluorescent imaging methods, potentially redefining the multiplexing capabilities of antibody-based assays.

Indexed as

Microscopy, FluorescenceSingle-Domain AntibodiesAnimalsFluorescent DyesHumansMicroscopy, ConfocalFluorescent DyesSingle-Domain Antibodies

Identifiers

PMID39384781
PMCPMC11479620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.